leisure time -WSS

leisure time

author：knowledge 2025-08-22 17:23:05 - browse：7723

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： CDC overhauls leadership of center that led response to Covid

entertainment

WSS

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Some of the ways extreme heat will change life as we know it

After John Oliver segment, STAT readers share their opioid

Target recalls 2.2 million additional candles due to laceration, burn hazards

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

'Cuddling' is just what the doctor ordered for a 200

focus

leisure time

focus

Bright Health sells Medicare Advantage business to Molina

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Malaria cases in Florida and Texas: Here’s what you need to know

After John Oliver segment, STAT readers share their opioid

Duchenne breakthrough therapy leaves behind pioneering families

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

Medical leaders decry Supreme Court decision on affirmative action

Listen: Your guide to Wegovy's blockbuster heart study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

GOP presidential candidates start declaring their loyalty

explore

Timeline: Special counsel's investigation into Trump's handling of classified documents

Who are the detained American citizens released from prison in Iran?

Slain Parkland victim's father speaks out following reenactment

Medical mystery: When an infection after surgery isn’t what it seems

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Parkland mass shooting to be reenacted for lawsuit

entertainment

entertainment

focus

knowledge